Filed: 5/15/2025ACC: 0001937964-25-000004
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 32 equity positions with a total reported market value of $395.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
32
Positions
$395.10M
Total AUM (reported)
5.05M
Total Shares
Allocation by class
COM$294.82M74.6%
SPONSORED ADS$34.70M8.8%
COM PAR $.01$24.28M6.1%
SPONSORED ADR$21.87M5.5%
COMMON STOCK$15.03M3.8%
COM NEW$3.45M0.9%
SPON ADS$948.1K0.2%
Portfolio Concentration
Top 3$202.27M51.2%
4–10$129.41M32.8%
11–25$57.80M14.6%
Rest$5.61M1.4%
Top 3 weight
51.2%
Top 10 weight
83.9%
Voting Authority Distribution
Total shares with voting rights: 5.05M
Sole
Full voting authority
5.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole32
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings32
Rows:
ELI LILLY & CO
SOLEShares139.89K
TypeSH
Market value$115.53M
29.24%
Sole
139.89K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares735.37K
TypeSH
Market value$52.54M
13.30%
Sole
735.37K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares538.49K
TypeSH
Market value$34.19M
8.65%
Sole
538.49K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares219.72K
TypeSH
Market value$28.99M
7.34%
Sole
219.72K
Shared
0.00
None
0.00
INSMED INC
SOLEShares318.24K
TypeSH
Market value$24.28M
6.14%
Sole
318.24K
Shared
0.00
None
0.00
MERUS N V
SOLEShares424.64K
TypeSH
Market value$17.87M
4.52%
Sole
424.64K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares333.85K
TypeSH
Market value$16.15M
4.09%
Sole
333.85K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares229.09K
TypeSH
Market value$15.03M
3.80%
Sole
229.09K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$14.02M
3.55%
Sole
190.75K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares129.70K
TypeSH
Market value$13.08M
3.31%
Sole
129.70K
Shared
0.00
None
0.00
QUEST DIAGNOSTICS INC
SOLEShares56.72K
TypeSH
Market value$9.60M
2.43%
Sole
56.72K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares28.60K
TypeSH
Market value$7.72M
1.95%
Sole
28.60K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares11.31K
TypeSH
Market value$6.69M
1.69%
Sole
11.31K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares90.75K
TypeSH
Market value$6.44M
1.63%
Sole
90.75K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares172.19K
TypeSH
Market value$5.54M
1.40%
Sole
172.19K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares104.19K
TypeSH
Market value$3.68M
0.93%
Sole
104.19K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares50K
TypeSH
Market value$2.65M
0.67%
Sole
50K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares53.93K
TypeSH
Market value$2.38M
0.60%
Sole
53.93K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares90.28K
TypeSH
Market value$2.18M
0.55%
Sole
90.28K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares160K
TypeSH
Market value$2.16M
0.55%
Sole
160K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares54.52K
TypeSH
Market value$2.15M
0.54%
Sole
54.52K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares3.50K
TypeSH
Market value$1.73M
0.44%
Sole
3.50K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares316.70K
TypeSH
Market value$1.72M
0.43%
Sole
316.70K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares14.70K
TypeSH
Market value$1.63M
0.41%
Sole
14.70K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares5K
TypeSH
Market value$1.54M
0.39%
Sole
5K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ELI LILLY & COSOLE | COM | 139.89K | SH | $115.53M 29.24% | 139.89K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 735.37K | SH | $52.54M 13.30% | 735.37K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 538.49K | SH | $34.19M 8.65% | 538.49K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 219.72K | SH | $28.99M 7.34% | 219.72K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 318.24K | SH | $24.28M 6.14% | 318.24K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 424.64K | SH | $17.87M 4.52% | 424.64K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 333.85K | SH | $16.15M 4.09% | 333.85K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 229.09K | SH | $15.03M 3.80% | 229.09K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $14.02M 3.55% | 190.75K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 129.70K | SH | $13.08M 3.31% | 129.70K | 0.00 | 0.00 |
QUEST DIAGNOSTICS INCSOLE | COM | 56.72K | SH | $9.60M 2.43% | 56.72K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 28.60K | SH | $7.72M 1.95% | 28.60K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 11.31K | SH | $6.69M 1.69% | 11.31K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 90.75K | SH | $6.44M 1.63% | 90.75K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 172.19K | SH | $5.54M 1.40% | 172.19K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 104.19K | SH | $3.68M 0.93% | 104.19K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 50K | SH | $2.65M 0.67% | 50K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 53.93K | SH | $2.38M 0.60% | 53.93K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 90.28K | SH | $2.18M 0.55% | 90.28K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 160K | SH | $2.16M 0.55% | 160K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 54.52K | SH | $2.15M 0.54% | 54.52K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 3.50K | SH | $1.73M 0.44% | 3.50K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 316.70K | SH | $1.72M 0.43% | 316.70K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 14.70K | SH | $1.63M 0.41% | 14.70K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 5K | SH | $1.54M 0.39% | 5K | 0.00 | 0.00 |
Page 1 of 2